模板1
Dear Prof. XXXXX,
Here within enclosed is our paper for consideration to be published on “(Journal name)”. The further information about the paper is in the following:
The Title: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
The Authors: XXXXXXXXXX XXXXXXXXXXXX and XXXXXXXXXX
The authors claim that none of the material in the paper has been pub
lished or is under consideration for publication elsewhere.
I am the corresponding author and my address and other information is as follows,
Address: Department of XXXXXXXXX,
Tsinghua University,
Beijing, 10084,
E-mail:
Tel: 86-
Fax: 86-
Thank you very much for consideration!
Sincerely Yours,
Dr. XXXXXXXXXXX
模板2
Dear XX (Editor):
Here is our paper submitted to "(XX Journal)".
The Title: XXXX
The Authors: XXX XXX and XXX
In this paper, we ...
The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere.
The corresponding author is Dr. XXX and his address and other information is as following:
Address: Department of XXX, XX University, ...,
Tel: +86-xxx-xxxxxxxx
Fax: +86-xxx-xxxxxxxx
Thank you very much for consideration!
Sincerely Yours,
Dr. xxx
模板3
Dear Mr. **
We believe the paper may be of particular interest to the readers of your journal as it ........
1. The work described has not been submitted elsewhere for publication, in whole or in part, and all the authors listed have approved the manuscript that is enclosed.
2. I have read and have abided by the statement of ethical standards for manuscripts submitted to Neuroscience.
kind regards.
Your sincerely,
通讯作者
Dear Prof. Gil:
This is a manuscript by**and **entitled “.......”. It is submitted to be considered for publication as a “...” in your journal. This paper is new. Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal.
Correspondence should be addressed to **at the following address, phone and fax number, and email address:
...
Thanks very much for your attention to our paper.
Sincerely yours,**
投稿信模版四（实例）
Case 1
Dear Editor,
We would like to submit the enclosed manuscript entitled "GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons", which we wish to be considered for publication in Nature Neuroscience.
GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parki nson’s disease.
Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I am
Sincerely yours,
case2
Dear Editor,
We would like to submit the enclosed manuscript entitled
"Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release", which we wish to be considered for publication in Neuron.
We believe that two aspects of this manuscript will make it interesting to general readers of Neuron. First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a neurotrophic factor. Our findings may also have general implications in the cell biology of neurotransmitter release.
Highlights
Highlights are a short collection of bullet points that convey the core findings and provide readers with a quick textual overview of the article. These three to five bullet points describe
the essence of the research . results or conclusions) and highlight what is distinctive about
it.
Highlights will be displayed in online search result lists, the contents list and in the online article, but will not (yet) appear in the article PDF file or print.
Author instructions:
Highlights should be submitted as a separate file in EES by selecting "Highlights" from the
drop-down list when uploading files. Please adhere to the specifications below.
Examples
Journal of Health Economics, Volume 29, Issue 4, July 2010, 524-535
Highlights
We model two hospitals which have regulated prices and compete on quality.
We examine changes in the level of information about hospital quality.
Increasing information will increase quality if hospital costs are similar.
Increasing information will decrease quality if hospital costs are very different.
Welfare effects depend on ex-ante or ex-post assumptions about quality information.
Applied Catalysis A, General, Volumes 411-412, 16 January 2012, 7-14
Highlights
Highly c-axis oriented ZnO nanowires were grown on glass using aqueous solutions.
The growth temperature does not exceed 95 °C in any step of the synthesis.
The photocatalytic and wetting properties were studied upon UV irradiation.
ZnO nanowires show superior photocatalytic activity.
We report a reversible photo-induced transition from hydrophobic to super-hydrophilic.
Biochimica et Biophysica Acta (BBA), Bioenergetics, Volume 1807, Issue 10, October 2011, 1364-1369
Highlights
A conformational two-state mechanism for proton pumping complex I is proposed.
The mechanism relies on stabilization changes of anionic ubiquinone intermediates.
Electron-transfer and protonation should be strictly controlled during turnover.
The mechanism explains the full reversibility of complex I.
Learning and Instruction, Volume 21, Issue 6, December 2011, 746-756
Highlights
Fading of a script alone does not foster domain-general strategy knowledge.
Performance of the strategy declines during the fading of a script.
Monitoring by a peer keeps performance of the strategy up during script fading.
Performance of a strategy after fading fosters domain-general strategy knowledge.
Fading and monitoring by a peer combined foster domain-general strategy knowledge.
外贸英语函电的写作格式常用范文 外贸函电涉及到的知识很广泛，那么外贸函电的英语写作格式需要注意哪些问题呢，接下来为大家整理了外贸英语函电的写作格式，希望对你有帮助哦! 1.请求建立商业关系 Rogers Chemical Supply Co. 10E.22Street Omaha8,Neb Gentlemen: We have obtained your name and address from Aristo Shoes, Milan , and we are writing to enquire whether you would be willing to establish business relations with us. We have been importers of shoes for many years. At present, We are interested in extending our, range and would appreciate your catalogues and quotations.If your prices are competitive we would expect to transact a significant volume of business. We look forward to your early reply. Very truly yours 自米兰职权里斯托鞋类公司取得贵公司和地址，特此修函，祈能发展关系。多年来，本公司经营鞋类进口生意，现欲扩展业务范围。盼能惠赐商品目录和报价表。如价格公道，本公司必大额订购。烦请早日赐复。此致 2.回复对方建立商业关系的请求 Thank your for your letter of the 16th of this month. We
英文论文投稿信Cover letter模板 qiusuo BY - 2006-1-17 8:59:00 Dear Editor, We would like to submit the enclosed manuscript entitled "GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons", which we wish to be considered for publication in Nature Neuroscience. GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease. Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I am Sincerely yours, case2 Dear Editor, We would like to submit the enclosed manuscript entitled "Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release", which we wish to be considered for publication in Neuron. We believe that two aspects of this manuscript will make it interesting to general readers of Neuron. First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a
外贸函电常用句式 1.Your enquiry is having our immediate attention and we hope to make you an acceptable offer in a few days.我们正在研究你方的询盘几天便可以给你合适的报盘 2.We thank you for your enquiry of July 6 and are sending you, under separate cover, a specimen of ….together with our price list 感谢你方关于7月6号的询盘现另寄上…的样品及价格回单。 3.Thank you for your recent enquiry ,we have a large quantity of …..in stock, and are pleased to offer them as follows.感谢你方最近的询盘，我们有大量的….的库存，欣为报盘如下。 4.With reference to your letter of ….,enquiring for …,we enclose our quotation No….for your consideration and trust you will find our prices accepted .关于你方…来函询购…..，兹附上第…..号的报价单供你方考虑，我们相信你们会认为我们的价格是可以接受的。 5.This offer is subject to the goods being unsold on receipt of your reply 6.本报盘以你方复到时货尚未售出的有效 7.Our best offer is given below subject to our final confirmation 8.现报最低价如下须经由我方的最后确认为有效 9.We must stress that this offer is for two days only because of the heavy demand for the limited supplies of this ….in stock.我们必须强调此报价在两天内有效，因为该…..的需求量极大但库存有限 10.This offer must be withdraw if not accepted within three days 此盘三天内不接 受就做撤销论 11.This offer is open for three days only此盘有效期仅三天 12.This offer expires on august 20 ,your immediate reply by cable will be appreciated. 13.该盘在8月20号失效请即回电 14.We wish to state that our quotations are subject to alternation without notice and to our confirmation at the time of placing your order 我们的报盘可以随时变动
一、投稿信 1. Dear Dr. Defendi ML: I am sending a manuscript entitled “” by – which I should like to submit for possible publication in the journal of - . Yours sincerely 2. Dear Dr. A: Enclosed is a manuscript entitled “” by sb, which we are submitting for pub lication in the journal of - . We have chosen this journal because it deals with - . We believe that sth would be of interest to the journal’s readers. 3. Dear Dr. A: Please find enclosed for your review an original research article, “” by sb. All authors have read and approve this version of the article, and due care has been taken to ensure the integrity of the work. No part of this paper has published or submitted elsewhere. No conflict of interest exits in the submission of this manuscript, and we have attached to this letter the signed letter granting us permission to use Figure 1 from another source. We appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers. 二、询问有无收到稿件 Dear Editors, We dispatched our manuscript to your journal on 3 August 2006 but have not, as yet, receive acknowledgement of their safe arrival. We fear that may have been lost and should be grateful if you would let us know whether or not you have received them. If not, we will send our manuscript again. Thank you in advance for your help. 三、询问论文审查回音 Dear Editors， It is more than 12 weeks since I submitted our manuscript (No: ) for possible publication in your journal. I have not yet received a reply and am wondering whether you have reached a decision. I should appreciated your letting me know what you have decided as soon as possible. 四、关于论文的总体审查意见 1. This is a carefully done study and the findings are of considerable interest. A few minor revision are list below. 2. This is a well-written paper containing interesting results which merit publication. For the benefit of the reader, however, a number of points need clarifying and certain statements require further justification. There are given below. 3. Although these observation are interesting, they are rather limited and do not advance our knowledge of the subject sufficiently to warrant publication in PNAS. We suggest that the authors try submitting their findings to specialist journal such as – 4. Although this paper is good, it would be ever better if some extra data were added. 5. This manuscript is not suitable for publication in the journal of –because the main observation it describe was reported 3 years ago in a reputable journal of - . 6. Please ask someone familiar with English language to help you rewrite this paper. As you will see, I have made some correction at the beginning of the paper where some syntax is not satisfactory. 7. We feel that this potentially interesting study has been marred by an inability to communicate the finding correctly in English and should like to suggest that the authors seek the advice of someone with a
1、Telex released b/l 电放提单 2、for your reference 做为你的参考 3、sign back 签回 4、Pls see attachment 请看附件 5、Pls sign back the telex releae letter . 请签回电放信 6、Pls find attached SO for your reference (yr ref.) 请查收附件做为你的参考 7、Pls make sure your cargo will send to our warehouse before tomorrow afternoon(18:00pm). 请尽量将你的货在明天下午6点前送到我们的仓库 8、Pls see attchment and cfm the b/l of XXX. 请收附件并且确认提单为XXX是否OK 9、I receipted the telex released requirment , but no payment receipt , we can’t telex release this mail it to me hurry! 我有收到电放函，但未收到付款收据，请尽快Email过来，否则我们不能电放此票货物。 10、Any further question, pls feel free to contact me, tks! 有任何问题，请及时联络我 11、Enclosed booking form for yr ref, pls fill it out by return 附件所涵内容给你参考，请填好后回传给我
SCI 投稿Cover letter模板大全 1. 第一次投稿Cover letter：主要任务是介绍文章主要创新以及声 明没有一稿多投 Dear Editors: We would like to submit the enclosed manuscript entitled “Paper Title”, which we wish to be considered for publication in “Journal Name”. No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. All the authors listed have approved the manuscript that is enclosed. In this work, we evaluated …… (简要介绍一下论文的创新性). I hope this paper is suitable for “Journal Name”. The following is a list of possible reviewers for your consideration: 1) Name A E-mail: ××××@×××× 2) Name B E-mail: ××××@×××× We deeply appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers. If you have any queries, please don’t hesitate to contact me at the address below. Thank you and best regards. Yours sincerely, ××××××Corresponding author: Name: ××× E-mail: ××××@×××× 2. 催稿信：询问稿件处理到声明步骤 Dear Prof. ×××: Sorry for disturbing you. I am not sure if it is the right time to contact you to inquire about the status of my submitted manuscript titled “Paper Title”. (ID: 文章稿号), although the status of “With Editor” has been lasting for more than two months, since submitted to journal three months ago. I am just wondering that my manuscript
分享两篇SCI发表的经历 三年前对于我来说SCI就是天书一样，在我踏进博士的门槛后我以为自己进入了地狱，也纠结也彷徨，整天刷虫友们对于博士、SCI的帖子，我选择了虫友们鼓励的那一部分来激励自己继续前行。我告诉自己坚持就是胜利，当然那是积极的坚持。在好几月之前就有这个想法，今天早上收到第二篇的接收通知后，我便想今天一定要在小木虫上谢谢那些给予我帮助的虫友们。 话不多说，我把自己这两篇投稿的经历与大家共享，希望能给大家带来一点点用处。 第一篇发表在Fitoterapia Cover letter Dear Editor Verotta: We would like to submit the manuscript entitled "××××××题目" by ××××××所有作者姓名which we wish to be considered for publication in Journal of Fitoterapia. All authors have read and approved this version of the article, and due care has been taken to ensure the integrity of the work. Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal. We believe the paper may be of particular interest to the readers of your journal as it is the first time of ××××××研究的精华所在 Thank you very much for your reconsidering our revised manuscript for potential publication in Fitoterapia. We are looking forward to hearing from you soon. Correspondence should be addressed to Jinhui Yu at the following address, phone and fax number, and email address. 地址、学院、学校名称 Phone: + 86×××××× Fax number: + 86571××××××
Please do not adjust margins Please do not adjust margins Address here. Address here. Address here. ? Footnotes relating to the title and/or authors should appear here. Electronic Supplementary Information (ESI) available: [details of any supplementary information available should be included here]. See DOI: 10.1039/x0xx00000x Received 00th January 20xx, Accepted 00th January 20xx DOI: 10.1039/x0xx00000x Title Author Full Name,*a Author Full Name b and Author Full Name c Abstract text goes here. The abstract should be a single paragraph that summarises the content of the article A Headings are the primary heading type e.g. Introduction, Results and discussion, Experimental B Headings should always be subordinate to A headings e.g. Synthetic procedures, Materials and methods, Crystallography. C headings should always be subordinate to B headings e.g. General procedure for synthesis of compound X. The main paragraph text follows directly on here. The main text of the article should appear here with headings as appropriate. Conclusions The conclusions section should come in this section at the end of the article, before the acknowledgements. Conflicts of interest In accordance with our policy on Conflicts of interest please ensure that a conflicts of interest statement is included in your manuscript here. Please note that this statement is required for all submitted manuscripts. If no conflicts exist, please state that “There are no conflicts to declare”. Acknowledgements The acknowledgements come at the end of an article after the conclusions and before the notes and references. Notes and references ? Footnotes relating to the main text should appear here. These might include comments relevant to but not central to the matter under discussion, limited experimental and spectral data, and crystallographic data. § §§ etc. Citations should appear here in the format A. Name, B. Name and C. Name, Journal Title , 2000, 35, 3523; A. Name, B. Name and C. Name, Journal Title , 2000, 35, 3523. …
模板1 Dear Prof. XXXXX, Here within enclosed is our paper for consideration to be published on “(Journal name)”. The further information about the paper is in the following: The Title: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX The Authors: XXXXXXXXXX XXXXXXXXXXXX and XXXXXXXXXX The authors claim that none of the material in the paper has been pub lished or is under consideration for publication elsewhere. I am the corresponding author and my address and other information is as follows,
Address: Department of XXXXXXXXX, Tsingh ua University, Beijin g, 10084, E-mail: Tel: 86- Fax: 86- Thank you very much for consideration! Sincerely Yours, Dr. XXXXXXXXXXX
模板2 Dear XX (Editor): Here is our paper submitted to "(XX Journal)". The Title: XXXX The Authors: XXX XXX and XXX In this paper, we ... The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere. The corresponding author is Dr. XXX and his address and other information is as following: Address: Department of XXX, XX University, ..., Tel: +86-xxx-xxxxxxxx
给一个答复审稿人意见的coverletter,希望对大家有帮助 Cover letter Manuscript number: BXXXXXK MS Type: Article Title: "XXXX" Correspondence Author: XXX Dear Dr. Fay Riordan: Thank you very much for your attention and the referee’s evaluation and comments on our paper BXXXXK. We have revised the manuscript according to your kind advices and referee’s detailed suggestions. Enclosed please find the responses to the referees. We sincerely hope this manuscript will be finally acceptable to be published on XXX. Thank you very much for all your help and looking forward to hearing from you soon. Best regards Sincerely yours Dr. XXX Please find the following Response to the comments of referees: Response to the referee’s comments Referee A Comment 1: The titania material formed after calcining at 450 oC is not characterized. XRD of these calcined materials should be provided to understand the crystallinity and phase. Response: Thanks for the referee’s kind suggestion. According to his/her advices, X-ray diffractometry spectroscopy (XRD) of the calcined TiO2 film was given in Supporting Information (Figure S1) in this revised version. It illustrated that the hydrothermal synthesized TiO2 materials after calcining at 450 oC is entire anatase, which was confirmed by the X-ray diffractometer with Cu Kα radiation (Rigaku D/ max-2500). Comment 2: The authors must state the mechanical strength of these materials after the removal of PS by calcinations. Response: Thanks for the referee’s suggestion. By a scotch tape peel test, the TiO2 film can’t be stripped from the conducting glass substrate, which indicates that the mechanical strength of as-prepared composite film is strong enough for the fabrication of solar cell devices. The revised details can be found in Line 165-168, page 2. Referee B Comment 1: The microtube structure with the size of 500-800 nm cannot only scatter the visible light in the region of 500-800 nm, but also can scatter more efficiently the visible light in the region below 500 nm, and can scatter near infrared light. This point should be clarified in the main text. Response: Thanks for the referee’s kind advice. Just like what the referee said, the microtube network structure can scatter not only visible light but also near infrared light. We added this point in revised manuscript and the detailed revision can be found in Line 194-205, Page 2-3.
目录 Chapter 1 建立贸易关系 1. 请求建立贸易关系 Request for Establishing Business Relations 2. 回复请求建立业务关系 Reply to the Request for Establishing Business Relations 3. 索取产品资料 Request for Product Literature 4. 回复索取产品资料 Reply to the Request for Product Literature 5. 邀请会面 Invitation to the Business Appointment 6. 接受会面邀请 Accepting the Invitation to the Business Appointment 7. 谢绝会面邀请 Declining the Invitation to the Business Appointment 8. 要求更改会面时间及地点Request for Changing the Time & Place of the Meeting Chapter 2 推销 9. 向特定客户推销 Sales Letter to Specific Customers 10. 向不特定客户推销 Sales Circular to Non-Specific Customers 11. 寄信给老客户 Sales Letter to Old Customers 12. 寄信给新客户 Sales Letter to New Customers 13. 推销新产品 Sales Letter for Promotion of New Products 14. 推销劳务 Sales Letter for Promotion of Labor Services Chapter 3 询盘和订货 15. 一般询盘 General Inquiry 16. 回复一般询盘 Reply to the General Inquiry 17. 具体询盘 Specific Inquiry 18. 报虚盘 Making a Non-Firm Offer 19. 报实盘 Making a Firm Offer 20. 买方还盘 Making a Counter Offer 21. 卖方返还盘 Making a Counter-Counter Offer 22. 下订单 Placing an Order 23. 接受订单 Accepting an Order 24. 拒绝订单 Declining an Order 25. 下续订单 Placing a Repeat Order 26. 推荐替代品 Offering a Substitute Product 27. 接受替代品 Accepting a Substitute Product 28. 拒绝替代品 Declining a Substitute Product 29. 涨价通知 Notice for Price Increase 30. 回复涨价通知 Reply to the Price Increase Notice Chapter4 付款 31. 询问付款方式 Asking about Payment Terms 32. 接受付款方式 Accepting Payment Terms
Case 1 Dear Editor, We would like to submit the enclosed manuscript entitled "GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons", which we wish to be considered for publication in Nature Neuroscience. GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease. Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I am Sincerely yours, case2 Dear Editor, We would like to submit the enclosed manuscript entitled "Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release", which we wish to be considered for publication in Neuron. We believe that two aspects of this manuscript will make it interesting to general readers of Neuron. First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a neurotrophic factor. Our findings may also have general implications in the cell biology of neurotransmitter release. 某杂志给出的标准Sample Cover Letter Case 3 Sample Cover Letter Dear Editor of the : Enclosed is a paper, entitled "Mobile Agents for Network Management." Please accept it as a candidate for publication in the . Below are our responses to your submission requirements. 1. Title and the central theme of the article. Paper title: "Mobile Agents for Network Management." This study reviews the concepts of mobile agents and distributed network management system. It proposes a mobile agent-based implementation framework and creates a prototype system to demonstrate the superior performance of a mobile agent-based network over the conventional client-server architecture in a large network environment.